Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000489375 | SCV000577189 | uncertain significance | not provided | 2017-04-07 | criteria provided, single submitter | clinical testing | The A7376V variant has not been published as a pathogenic variant, nor has it been reported as a benign variant to our knowledge. The A7376V variant is not observed at a significant frequency in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). This variant is a conservative amino acid substitution, which is not likely to impact secondary protein structure as these residues share similar properties. Additionally, missense variants in nearby residues have not been reported in the Human Gene Mutation Database in association with nemaline myopathy (Stenson et al., 2014). However, this substitution occurs at a position that is conserved across species, and in silico analysis is inconsistent in its predictions as to whether or not the variant is damaging to the protein structure/function. |
Labcorp Genetics |
RCV001835827 | SCV004301764 | likely benign | Nemaline myopathy 2 | 2023-10-04 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001835827 | SCV002084048 | uncertain significance | Nemaline myopathy 2 | 2019-11-11 | no assertion criteria provided | clinical testing |